Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P22
Within normal range
vs 2Y Ago
-0.8x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -13.23% |
| 2024 | 46.69% |
| 2023 | 16.20% |
| 2022 | -34.05% |
| 2021 | -9.43% |
| 2020 | -17.52% |
| 2019 | 53.51% |
| 2018 | 53.66% |
| 2017 | 223.17% |
| 2016 | 0.00% |